APPLICATIONS PUBLISHED 26 MAY 2004

Published: 1-Dec-2004

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492

  • Pharmaceutical compsns for the treatment of asthma
    Schering Corp 1420759*

  • Aerosolised decongestants for the treatment of sinusitis
    Sinuspharma 1420760*

  • Solid phase synthesis of salts of organic acid
    Kemin Industries 1420761*

  • Residual solvent extraction method and microparticles produced thereby
    Alkermes Controlled Therapeutics 1420762*

  • Stable pharmaceutical compsns comprising acid labile benzimidazoles
    Takeda Chemical Industry 1420763*

  • Multi-part dental bleaching systems and method for bleaching teeth using such systems
    Uktradent Products 1420764*

  • Injection moulding process for the preparation of an oral delivery device for a pharmaceutical active agent
    SmithKline Beecham 1420765*

  • Bilayered dispersible tablet formulation comprising amoxycillin and clavulanate in separate layers
    Cimex 1420766*

  • Compsns containing itraconazole and their preparation methods
    Won Jin Biopharma; Lee, Beom Jin 1420767*

  • Methods and compsns for regulating memory consolidation
    Sention 1420768*

  • Lipid profile modulation with steroids
    The University of Edinburgh 1420769*

  • Photoreactive compounds and compsns
    The University Court of the University of Edinburgh 1420770*

  • Use of trifluoroacetyl alkyl-substituted phenyl derivatives, phenol derivatives, and benzoyl derivatives in the treatment and/or prophylaxis of obesity and accompanying diseases and/or secondary diseases
    Solvay Pharmaceuticals 1420771*

  • Use of beta-adrenoreceptor agonists for the treatment of neurodegenerative diseases
    Eucro European Contract Research 1420772*

  • Amidine derivatives for treating amyloidosis
    Neurochem (International); Chalifour, Robert; Kong, Xianqi; Wu, Xinfu 1420773*

  • Preparations and diabetic use of gibberellins
    Australian Biochemical Company 1420774*

  • Platinum complexes and their use in cancer treatment
    Yissum Research Development Company of the Hebrew University of Jerusalem 1420775*

  • Drugs and treatment of cerebral injury and methods of use thereof
    CLF Medical Technology Acceleration Program 1420776*

  • Pharmaceutical compsns containing beta-lapachone, or derivatives or analogues thereof, and methods of using the same
    Arqule 1420777*

  • Use of MEK inhibitors for treating inflammation and virus-induced haemorrhagic shock
    Bevec, Dorian 1420778*

  • Process for isolating phenolic compounds
    Cargill 1420779*

  • Cyclopropoyl and cyclobutyl epothilone analogues
    Novartis 1420780*

  • Analgetic pyrroline derivatives
    Endo Pharmaceuticals 1420781*

  • Use of nefiracetam for treating neurodegeneration
    Daiichi Pharmaceutical 1420782*

  • Stable emulsion compsn
    Takeda Chemical Industries 1420783*

  • Compounds effecting glucokinase
    AstraZeneca 1420784*

  • Substituted indeno 1,2-C]isoquinoline derivatives and methods of use thereof
    Inotek Pharmaceuticals Corp 1420785*

  • Methods of inhibiting formation of vascular channels and proliferation using pyridinone derivatives
    The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services 1420786*

  • Ophthalmic compsn comprising an ascomycin
    Novartis Pharma 1420787*

  • Novel piperidin-2,6-dione bisulphate salts and their use for the treatment of stress-related affective disorders
    Prestwick Pharmaceuticals 1420788*

  • Use of active ingredients having a (m)-opioid receptor agonist action, as combination drugs for the treatment of cancer
    PAZ Arzneimittel-Entwicklungsgesellschaft 1420789*

  • Use of BIBN4096 in combination with other antimigraine drugs for the treatment of migraine
    Boehringer Ingelheim Pharma 1420790*

  • Use of compounds for treating conditions resulting from injury to the corneal nerve after lasik and other ocular surgeries or trauma
    Alcon 1420791*

  • Products and drug delivery vehicles
    SmithKline Beecham 1420792*

  • Method and compsn for treatment of ocular hypertension and glaucoma
    Sucampo 1420793*

  • Prostaglandin analogues as chloride channel opener
    Sucampo 1420794*

  • As-needed administration of androgenic agent to enhance female sexual desire and responsiveness
    Vivus 1420795*

  • Androgen receptor modulators and methods of use thereof
    Merck & Co 1420796*

  • Dermal therapy using phosphate derivatives of electron transfer agents
    Vital Health Services 1420797*

  • Treatment and prevention of heat shock protein-associated diseases and conditions
    Eisai 1420798*

  • Use of atazanavir in HIV therapy
    Bristol-Myers Squibb 1420799*

  • Modulator of insulin-regulated aminopeptidase (IRAP)/angiotensin IV (AT4) receptor activity
    Howard Florey Institute of Experimental Physiology and Medicine 1420800*

  • Use of fucans in the treatment of adhesions, arthritis and psoriasis
    The University of British Columbia 1420801*

  • Increased solubility flavanolignan preparations
    Ivax CR 1420802*

  • Method for amplifying expression from a cell-specific promoter
    Board of Regents, The University of Texas System 1420803*

  • Methods and compsns for control of coccidiosis
    Alltech 1420804*

  • Aromatase marking
    Schmidt, Alfred; Wieland, Heinrich 1420805*

  • Triple polypeptide complexes
    Arexis 1420806*

  • Platelet-derived growth factor protection of cardiac myocardium
    Cornell Research Foundation 1420807*

  • Treatment of tuberculosis using immunomodulator compounds
    Sciclone Pharmaceuticals 1420808*

  • Use of cyclopenta[G]quinazoline derivatives for treating cancer
    BTG International 1420809*

  • Modulation of leukocyte-endothelial interactions following ischaemia
    Genetics Institute 1420810*

  • Method and compsn for prophylaxis of diabetes
    Societe des Produits Nestle 1420811*

  • Use of leptin for infant with low birth-weight for prevention of obesity
    The University of Buckingham 1420812*

  • Pregnancy-related enzyme activity
    Prince Henry's Institute of Medical Research 1420813*

  • Compsn and methods for the therapy and diagnosis of breast cancer
    Corixa Corp 1420814*

  • Beta-amyloid analogue T-cell epitope vaccine
    Pharmexa 1420815*

  • Use of mammalian cytokine; related reagents
    Schering Corp 1420816*

  • Moraxella (branhamella) catarrhalis polypeptides and corresponding DNA fragments
    Shire Biochem 1420817*

  • Antigenic compsns
    Otago Innovation 1420818*

  • Sub-unit vaccine for infectious pancreatic necrosis virus
    University of Maryland Biotechnology Institute 1420819*
  • You may also like